Risk factors for hospital admission among COVID-19 patients with diabetes

References

1. ↵
   1. Ahmad T,
   2. Haroon Baig M,
   3. Hui J

   (2020) Coronavirus disease 2019 (COVID-19) pandemic and economic impact. Pak J Med Sci 36:S73–S78.

   OpenUrl
2. ↵
   1. World Health Organization

   COVID-19 as a Public Health Emergency of International Concern (PHEIC) under the IHR, Updated 2020, Available from URL: https://extranet.who.int/sph/covid-19-public-health-emergency-international-concern-pheic-under-ihr. Accessed 2020 August 12.
3. ↵
   1. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE). Johns Hopkins Whiting School of Engineering (JHU). ArcGIS

   Johns Hopkins University, Updated 2020, Available from URL: https://systems.jhu.edu/. Accessed 2020 July 16.
4. ↵
   1. The International Diabetes Federation (IDF)

   COVID-19 and diabetes, Updatde 2020, Available from URL: https://www.idf.org/aboutdiabetes/what-is-diabetes/covid-19-and-diabetes/1-covid-19-and-diabetes.html. Accessed 2020 August 13.
5. ↵
   1. Azar WS,
   2. Njeim R,
   3. Fares AH,
   4. Azar NS,
   5. Azar ST,
   6. El Sayed M,
   7. et al.

   COVID-19 and diabetes mellitus:how one pandemic worsens the other. Rev Endocr Metab Disord 2020:1–13.
6. ↵
   1. Gupta R,
   2. Hussain A,
   3. Misra A

   (2020) Diabetes and COVID-19:evidence, current status and unanswered research questions. Eur J Clin Nutr 74:864–870.

   OpenUrlCrossRef
7. ↵
   1. Jeong IK,
   2. Ho Yoon K,
   3. Kyu Lee M

   (2020) Diabetes and COVID-19:global and regional perspectives. Diabetes Res Clin Pract 166:108303.

   OpenUrl
8. ↵
   1. Belkhadir J

   (2020) COVID-19 and diabetes from IDF MENA region. Diabetes Res Clin Pract 166:108277.

   OpenUrl
9. ↵
   1. Katulanda P,
   2. Dissanayake HA,
   3. Ranathunga I,
   4. Ratnasamy V,
   5. Wijewickrama PSA,
   6. Yogendranathan N,
   7. et al.

   (2020) Prevention and management of COVID-19 among patients with diabetes:an appraisal of the literature. Diabetologia 63:1440–1452.

   OpenUrl
10. ↵
    1. International Diabetes Federation (IDF)

    Diabetes Atlas 19th Edition, Updated 2019, Available from URL: https://diabetesatlas.org/en/resources/. Accessed 2020 August 7.
11. ↵
    1. Ministry of Health

    Saudi MOH Protocol for Patients Suspected of/Confirmed with COVID-19, Updated 2020 July 31, Available from URL: https://www.moh.gov.sa/Ministry/MediaCenter/Publications/Documents/MOH-therapeutic-protocol-for-COVID-19.pdf. Accessed 2020 August 12.
12. ↵
    1. Rajpal A,
    2. Rahimi L,
    3. Ismail-Beigi F

    (2020) Factors leading to high morbidity and mortality of COVID-19 in patients with type 2 diabetes. J Diabetes, 1–14.
13. ↵
    1. Koliaki C,
    2. Tentolouris A,
    3. Eleftheriadou I,
    4. Melidonis A,
    5. Dimitriadis G,
    6. Tentolouris N

    (2020) Clinical management of diabetes mellitus in the era of COVID-19:practical issues, peculiarities and concerns. J Clin Med 9:2288.

    OpenUrl
14. ↵
    1. Zhou F,
    2. Yu T,
    3. Du R,
    4. Fan G,
    5. Liu Y,
    6. Liu Z,
    7. et al.

    (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China:a retrospective cohort study. Lancet 395:1054–1062.

    OpenUrlCrossRefPubMed
15. ↵
    1. Preito-Alhambra D,
    2. Ballo E,
    3. Coma E,
    4. Mora N,
    5. Aragon M,
    6. PratsUribe A,
    7. et al.

    (2020) Hospitalization and 30-day fatality in 121,263 COVID-19 outpatient cases. medRxiv, 1–19.
16. ↵
    1. Wang X,
    2. Wang S,
    3. Sun L,
    4. Qin G

    (2020) Prevalence of diabetes mellitus in 2019 novel coronavirus:A meta-analysis. Diabetes Res Clin Pract 164:108200.

    OpenUrlPubMed
17. ↵
    1. Singh AK,
    2. Khunti K

    (2020) Assessment of risk, severity, mortality, glycemic control and antidiabetic agents in patients with diabetes and COVID-19:A narrative review. Diabetes Res Clin Pract 165:108266.

    OpenUrl
18. ↵
    1. Jin JM,
    2. Bai P,
    3. He W,
    4. Wu F,
    5. Liu XF,
    6. Han DM,
    7. et al.

    (2020) Gender differences in patients with COVID-19:focus on severity and mortality. Front Public Health 8:152.

    OpenUrl
19. ↵
    1. Arentz M,
    2. Yim E,
    3. Klaff L,
    4. Lokhandwala S,
    5. Riedo FX,
    6. Chong M,
    7. et al.

    (2020) Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington state. JAMA 323:1612–1614.

    OpenUrlCrossRefPubMed
20. ↵
    1. Grasselli G,
    2. Zangrillo A,
    3. Zanella A,
    4. Antonelli M,
    5. Cabrini L,
    6. Castelli A,
    7. et al.

    (2020) Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA 323:1574–1581.

    OpenUrlCrossRefPubMed
21. ↵
    1. The Open SAFELY Collaborative,
    2. Williamson E,
    3. Walker AJ,
    4. Bhaskaran K,
    5. Bacon S,
    6. Bates C,
    7. et al.

    (2019) Factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients. J Chem Inf Model 53:1689–1699.

    OpenUrl
22. ↵
    1. Apicella M,
    2. Campopiano MC,
    3. Mantuano M,
    4. Mazoni L,
    5. Coppelli A,
    6. Del Prato S

    (2020) COVID-19 in people with diabetes:understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol 8:e5.

    OpenUrl
23. ↵
    1. Shi Q,
    2. Zhang X,
    3. Jiang F,
    4. Zhang X,
    5. Hu N,
    6. Bimu C,
    7. et al.

    (2020) Clinical characteristics and risk factors for mortality of COVID-19 patients with diabetes in Wuhan, China:a two-center, retrospective study. Diabetes Care 43:1382–1391.

    OpenUrlAbstract/FREE Full Text
24. ↵
    1. Chen Y,
    2. Yang D,
    3. Cheng B,
    4. Chen J,
    5. Peng A,
    6. Yang C,
    7. et al.

    (2020) Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication. Diabetes Care 43:1399–13407.

    OpenUrlAbstract/FREE Full Text
25. ↵
    1. Tartarone A,
    2. Lerose R

    (2020) COVID-19 and cancer care:what do international guidelines say? Med Oncol 37:80.

    OpenUrl
26. ↵
    1. Papadokostaki E,
    2. Tentolouris N,
    3. Liberopoulos E

    (2020) COVID-19 and diabetes:What does the clinician need to know? Prim Care Diabetes 14:558–563.

    OpenUrl
27. ↵
    1. Akbar DH

    1. Ceriello A,
    2. Standl E,
    3. Catrinoiu D,
    4. Itzhak B,
    5. Lalic NM,
    6. Rahelic D,
    7. et al.

    (2001) Issues for the management of people with diabetes and COVID-19 in ICU. Bacterial pneumonia:comparison between diabetics and non-diabetics. Cardiovasc Diabetol. 2020; 19: 114.E28. in Acta Diabetol, ed Akbar DH 38:77–82.

    OpenUrlCrossRefPubMedWeb of Science
28. ↵
    1. Bode B,
    2. Garrett V,
    3. Messler J,
    4. McFarland R,
    5. Crowe J,
    6. Booth R,
    7. Klonoff DC

    (2020) Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States. J Diabetes Sci Technol 14:813–821.

    OpenUrl
29. ↵
    1. Akbar DH

    (2001) Bacterial pneumonia:comparison between diabetics and non-diabetics. Acta Diabetol 38:77–82.

    OpenUrlCrossRefPubMedWeb of Science
30. ↵
    1. Shang J,
    2. Wang Q,
    3. Zhang H,
    4. Wang X,
    5. Wan J,
    6. Yan Y,
    7. et al.

    (2020) The relationship between diabetes mellitus and COVID-19 prognosis:a retrospective cohort study in Wuhan, China. Am J Med, 1–9.
31. ↵
    1. Kim NY,
    2. Ha E,
    3. Moon JS,
    4. Lee YH,
    5. Choi EY

    (2020) Response:Acute Hyperglycemic Crises with Coronavirus Disease-19:Case Reports (Diabetes Metab J 2020 44 349-53). Diabetes Metab J 44:484–485.

    OpenUrl